Application Sponsors
ANDA 211476 | TEVA PHARMS USA | |
Marketing Status
Application Products
001 | CAPSULE;ORAL | 5MG;2.5MG | 0 | CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2021-11-02 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
TEVA PHARMS USA
cder:Array
(
[0] => Array
(
[ApplNo] => 211476
[companyName] => TEVA PHARMS USA
[docInserts] => ["",""]
[products] => [{"drugName":"CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE","activeIngredients":"CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE","strength":"5MG;2.5MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"11\/02\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2021-11-02
)
)